Caveolin-1 and Dopamine-Mediated Internalization of NaKATPase in Human Renal Proximal Tubule Cells

In moderate sodium-replete states, dopamine 1–like receptors (D1R/D5R) are responsible for regulating >50% of renal sodium excretion. This is partly mediated by internalization and inactivation of NaKATPase, when associated with adapter protein 2. We used dopaminergic stimulation via fenoldopam (D1-like receptor agonist) to study the interaction among D1-like receptors, caveolin-1 (CAV1), and the G protein–coupled receptor kinase type 4 in cultured human renal proximal tubule cells (RPTCs). We compared 2 groups of RPTCs, 1 of cell lines that were isolated from normal subjects (nRPTCs) and a second group of cell lines that have D1-like receptors that are uncoupled (uncoupled RPTCs) from adenylyl cyclase second messengers. In nRPTCs, fenoldopam increased the plasma membrane expression of D1R (10.0-fold) and CAV1 (1.3-fold) and markedly decreased G protein–coupled receptor kinase type 4 by 94±8%; no effects were seen in uncoupled RPTCs. Fenoldopam also increased the association of adapter protein 2 and NaKATPase by 53±9% in nRPTCs but not in uncoupled RPTCs. When CAV1 expression was reduced by 86.0±8.5% using small interfering RNA, restimulation of the D1-like receptors with fenoldopam in nRPTCs resulted in only a 7±9% increase in association between adapter protein 2 and NaKATPase. Basal CAV1 expression and association with G protein–coupled receptor kinase type 4 was decreased in uncoupled RPTCs (58±5% decrease in association) relative to nRPTCs. We conclude that the scaffolding protein CAV1 is necessary for the association of D1-like receptors with G protein–coupled receptor kinase type 4 and the adapter protein 2–associated reduction in plasma membrane NaKATPase.

[1]  A. Cinelli,et al.  Trafficking of Na-K-ATPase and dopamine receptor molecules induced by changes in intracellular sodium concentration of renal epithelial cells. , 2008, American journal of physiology. Renal physiology.

[2]  Necmettin Yildirim,et al.  β2-Adrenergic Receptor Signaling and Desensitization Elucidated by Quantitative Modeling of Real Time cAMP Dynamics* , 2008, Journal of Biological Chemistry.

[3]  V. A. Villar,et al.  Lipid Rafts Keep NADPH Oxidase in the Inactive State in Human Renal Proximal Tubule Cells , 2008, Hypertension.

[4]  R. Felder,et al.  Differential D1 and D5 Receptor Regulation and Degradation of the Angiotensin Type 1 Receptor , 2008, Hypertension.

[5]  R. Felder,et al.  Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. , 2008, American journal of physiology. Heart and circulatory physiology.

[6]  P. Insel,et al.  Caveolae as organizers of pharmacologically relevant signal transduction molecules. , 2008, Annual review of pharmacology and toxicology.

[7]  J. Shapiro,et al.  Regulation of sodium pump endocytosis by cardiotonic steroids: Molecular mechanisms and physiological implications. , 2007, Pathophysiology : the official journal of the International Society for Pathophysiology.

[8]  R. Webb,et al.  Methyl-β-cyclodextrin Prevents Angiotensin II-Induced Tachyphylactic Contractile Responses in Rat Aorta , 2007, Journal of Pharmacology and Experimental Therapeutics.

[9]  A. Cinelli,et al.  Localization of intracellular compartments that exchange Na,K‐ATPase molecules with the plasma membrane in a hormone‐dependent manner , 2007, British journal of pharmacology.

[10]  Liat Abovich Gilad,et al.  Association of estrogen receptor β with plasma-membrane caveola components: implication in control of vitamin D receptor , 2007 .

[11]  C. Murga,et al.  The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. , 2007, Biochimica et biophysica acta.

[12]  Liat Abovich Gilad,et al.  Association of estrogen receptor beta with plasma-membrane caveola components: implication in control of vitamin D receptor. , 2007, Journal of molecular endocrinology.

[13]  R. Felder,et al.  Mechanisms of Disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity , 2006, Nature Clinical Practice Nephrology.

[14]  J. Bauersachs,et al.  Endothelial NO synthase target of aldosterone. , 2006, Hypertension.

[15]  F. Morón,et al.  Genetic analysis of CAV1 gene in hypertension and metabolic syndrome , 2006, Thrombosis and Haemostasis.

[16]  J. Lingrel,et al.  Physiological role of the α1- and α2-isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site , 2006 .

[17]  J. Lingrel,et al.  Physiological role of the alpha1- and alpha2-isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[18]  N. Vaziri,et al.  Effect of hereditary obesity on renal expressions of NO synthase, caveolin-1, AKt, guanylate cyclase, and calmodulin. , 2005, Kidney international.

[19]  A. Bertorello,et al.  Inhibition of Na,K-ATPase by dopamine in proximal tubule epithelial cells. , 2005, Seminars in nephrology.

[20]  J. Shapiro,et al.  Ouabain-induced endocytosis of the plasmalemmal Na/K-ATPase in LLC-PK1 cells requires caveolin-1. , 2005, Kidney international.

[21]  A. Katz,et al.  The 14-3-3 Protein Translates the NA+,K+-ATPase α1-Subunit Phosphorylation Signal into Binding and Activation of Phosphoinositide 3-Kinase during Endocytosis* , 2005, Journal of Biological Chemistry.

[22]  Z. Wang,et al.  D1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells. , 2004, Kidney international.

[23]  J. Zwiller,et al.  Hypertension-Linked Mutation in the Adducin &agr;-Subunit Leads to Higher AP2-&mgr;2 Phosphorylation and Impaired Na+,K+-ATPase Trafficking in Response to GPCR Signals and Intracellular Sodium , 2004, Circulation research.

[24]  M. Lokhandwala,et al.  Dopamine recruits D1A receptors to Na-K-ATPase-rich caveolar plasma membranes in rat renal proximal tubules. , 2004, American journal of physiology. Renal physiology.

[25]  P. Doris,et al.  Altered Subcellular Distribution of Na+, K+-ATPase in Proximal Tubules in Young Spontaneously Hypertensive Rats , 2004, Hypertension.

[26]  P. Jose,et al.  Defective D1-like receptor-mediated inhibition of the Cl-/HCO3- exchanger in immortalized SHR proximal tubular epithelial cells. , 2004, American journal of physiology. Renal physiology.

[27]  R. Felder,et al.  Perturbation of D1 Dopamine and AT1 Receptor Interaction in Spontaneously Hypertensive Rats , 2003, Hypertension.

[28]  A. Cinelli,et al.  Intracellular Na+ Regulates Dopamine and Angiotensin II Receptors Availability at the Plasma Membrane and Their Cellular Responses in Renal Epithelia* , 2003, Journal of Biological Chemistry.

[29]  R. Felder,et al.  Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4. , 2002, Kidney international.

[30]  Wei Wang,et al.  G protein-coupled receptor kinase 4 gene variants in human essential hypertension , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  O. Moe,et al.  Dopamine Acutely Stimulates Na+/H+Exchanger (NHE3) Endocytosis via Clathrin-coated Vesicles , 2001, The Journal of Biological Chemistry.

[32]  Jing Xu,et al.  D1 dopamine receptor regulation of NHE3 during development in spontaneously hypertensive rats , 2001 .

[33]  M. Haney,et al.  Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans , 2001, Psychopharmacology.

[34]  X. X. Li,et al.  D(1) dopamine receptor regulation of NHE3 during development in spontaneously hypertensive rats. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[35]  G. Seki,et al.  Dopamine inhibits renal Na+:HCO3- cotransporter in rabbits and normotensive rats but not in spontaneously hypertensive rats. , 2000, Kidney international.

[36]  R. Carey,et al.  Dopamine1 Receptor, Gs&agr;, and Na+-H+ Exchanger Interactions in the Kidney in Hypertension , 2000 .

[37]  P. Berggren,et al.  Phosphoinositide-3 kinase binds to a proline-rich motif in the Na+, K+-ATPase alpha subunit and regulates its trafficking. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. Soares-da-Silva,et al.  SALT INTAKE AND SENSITIVITY OF INTESTINAL AND RENAL NA+ -K+ ATPase TO INHIBITION BY DOPAMINE IN SPONTANEOUS HYPERTENSIVE AND WISTAR-KYOTO RATS , 2000, Clinical and experimental hypertension.

[39]  X. X. Li,et al.  Dopamine(1) receptor, G(salpha), and Na(+)-H(+) exchanger interactions in the kidney in hypertension. , 2000, Hypertension.

[40]  M. Lokhandwala,et al.  Defective renal dopamine D1-like receptor signal transduction in obese hypertensive rats. , 2000, Acta physiologica Scandinavica.

[41]  R. Felder,et al.  D1 dopamine receptor signalling defect in spontaneous hypertension. , 2000, Acta physiologica Scandinavica.

[42]  D. Bruns,et al.  Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. , 1999, Hypertension.

[43]  C. Carman,et al.  Regulation of G Protein-coupled Receptor Kinases by Caveolin* , 1999, The Journal of Biological Chemistry.

[44]  R. Felder,et al.  Effects of costimulation of dopamine D1- and D2-like receptors on renal function. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[45]  N. Olsen Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans. , 1998, Danish medical bulletin.

[46]  M. Lokhandwala,et al.  Renal dopamine DA1 receptor coupling with G(S) and G(q/11) proteins in spontaneously hypertensive rats. , 1997, The American journal of physiology.

[47]  R. Felder,et al.  Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status. , 1997, Hypertension.

[48]  D. Sibley,et al.  Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. , 1996, The Journal of clinical investigation.

[49]  A. Dębska-Ślizień,et al.  Endogenous dopamine regulates phosphate reabsorption but not NaK-ATPase in spontaneously hypertensive rat kidneys. , 1994, Journal of the American Society of Nephrology : JASN.

[50]  R. F. Cook,et al.  Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease , 1994, The Journal of cell biology.

[51]  A. Aperia,et al.  Dopamine regulation of renal Na+,K(+)-ATPase activity is lacking in Dahl salt-sensitive rats. , 1993, Hypertension.

[52]  M. Lokhandwala,et al.  Dopamine Fails to Inhibit Renal Tubular Sodium Pump in Hypertensive Rats , 1993, Hypertension.

[53]  M. Lokhandwala,et al.  An impairment of renal tubular DA-1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. , 1992, Clinical and experimental hypertension. Part A, Theory and practice.

[54]  A. Schoolwerth,et al.  Hormone responses of proximal Na(+)-H+ exchanger in spontaneously hypertensive rats. , 1991, The American journal of physiology.

[55]  C. Felder,et al.  Dopamine inhibits Na(+)-H+ exchanger activity in renal BBMV by stimulation of adenylate cyclase. , 1990, The American journal of physiology.

[56]  R. Felder,et al.  Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. , 1990, Hypertension.

[57]  F. Amenta,et al.  Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam. , 1989, The Journal of pharmacology and experimental therapeutics.

[58]  A. Sidhu,et al.  Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. , 1989, The Journal of clinical investigation.

[59]  R. Felder,et al.  Intrarenal dopamine acts at the dopamine‐1 receptor to control renal function , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[60]  R. Felder,et al.  Intrarenal dopamine-1 receptors control renal function. , 1988, Transactions of the Association of American Physicians.